Claw II
Payments companies reported to CMS as associated with Claw II. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Claw II, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Claw II
These are the largest totals companies reported as associated with Claw II. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Thomas Lee | Pickerington, OH | Foot and Ankle Surgery | $217,727.24 |
| Gregory Berlet | Worthington, OH | Orthopaedic Surgery | $88,796.28 |
| Douglas Blacklidge | Kokomo, IN | Foot & Ankle Surgery | $77,618.87 |
| Christopher Hyer | Worthington, OH | Foot & Ankle Surgery | $43,898.37 |
| Jamey Burrow | Jackson, MS | Orthopaedic Surgery | $12,876.59 |
| Gerard Cush | Lewisburg, PA | Orthopaedic Surgery | $4,416.48 |
| Scott Ellis | New York, NY | Foot and Ankle Surgery | $550.00 |
| Nadiya Yerich | Jbsa-Fort Sam Houston, TX | General Practice | $325.35 |
| Daniel Homeier | Fort Sam Houston, TX | General Practice | $325.35 |
| Demetrios Econopouly | North Bergen, NJ | Foot & Ankle Surgery | $304.44 |
Prescribed Claw II?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.